Skip to main content
Sign In

Connie Savor Price, MD

Associate Professor


Phone: 303-436-7481
Office address: Denver Health and Hospital, MC-4000, Denver CO 80238

Medical School
Northwestern University Feinberg School of Medicine, Chicago, IL

Northwestern University/Northwestern Memorial Hospital, Chicago, IL

Fellowship (Infectious Diseases)
National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland

Fellowship (Medical Microbiology)
Northwestern University/Northwestern Memorial Hospital, Chicago, IL


Dr. Connie Savor Price is Chief of the Division of Infectious Diseases at Denver Health Medical Center and Assistant Professor of Medicine at the University of Colorado Denver. Dr. Price is the primary investigator on an Agency for Healthcare Research and Quality (AHRQ) initiative toward reducing healthcare-associated infections and a co-investigator on a CDC-funded project in biosurveillance. She chairs the Infection Control and Prevention Committee, Antimicrobial Subcommittee, and Emerging Infectious Diseases Committee and directs the musculoskeletal infection clinic at Denver Health. Her specific research and clinical interests include innovative programs in methicillin-resistant Staphylococcus aureus (MRSA) control; hand-hygiene; use of molecular typing for infection control investigations; new technologies for the rapid diagnosis of infectious diseases. Other clinical and research interests focus on the treatment of musculoskeletal infections and the treatment of serious infections due to Staphylococcus aureus. In addition to her membership in the Infectious Diseases Society of America and American Society of microbiology, she is active in the Society of Healthcare Epidemiology of America and has served on a number of their professional committees, in addition to the Colorado Health Facility Acquired Infections Advisory Committee for mandatory infection reporting.

Pub Med Articles 


1) Johnson L, Sabel AL; Burman WJ, Everhart RM, Rome ME, Mackenzie TD, Rozwadowski J, Mehler PS; Price CS. Emergence of Fluoroquinolone Resistance in Outpatient Urinary Escherichia coli Isolates: Identification of Risk Factors and Re-evaluation of Treatment Strategies. Archives of Internal Medicine. Submitted September 7, 2007. In press.

2) Price CS, Williams A, Morgan S, Philips G, Dayton M, Smith W. Prevalence of Methicillin Sensitive and Resistant Staphylococcus aureus Nasal Colonization in Preoperative Orthopaedic Surgery Outpatients. Journal of Bone and joint Surgery, Submitted January, 2007. In press

3) Jenkins TC, Price CS, Sabel AL, Mehler PM, Burman WJ. Impact of Routine Infectious Diseases Service Consultation on the Evaluation, Management, and Outcomes of Staphylococcus aureus Bacteremia. Clinical Infectious Diseases. Accepted Nov 14, 2007. In press

4) Lalani, T; Boucher, H; Cosgrove, S; Fowler, V; Kanafani, Z; Vigliani, G; Campion, M; Abrutyn, E; Levine, DP; Price, C; Rehm, S; Corey, G; Karchmer, A. Outcomes with Daptomycin versus Standard Therapy for Osteoarticular Infections associated with Staphylococcus aureus Bacteremia. Journal of Antimicrobial Chemotherapy. Accepted Oct 16, 2007. In press

5) Young LS, Price CS. Community-Acquired Methicillin-Resistant Staphylococcus aureus Emerging As An Important Cause of Necrotizing Fasciitis. Surgical Infections. Accepted Sep 21, 2007. In press

6) Hanfling D, Price CS, Wyrick MK. Preparing for Pandemic Influenza: Adapting a Model of Healthcare Facility Preparedness to the Business Sector, Journal of Business Continuity & Emergency Planning. Accepted June 11, 2007. In press

7) Young LS, Price CS. Epidemiologic, clinical, and economic evaluation of a clonal multi-drug resistant Acinetobacter baumannii outbreak in a surgical intensive care unit. Infect Control Hosp Epidemiol. 2007 Nov;28(11):1247-54

8) Fowler VJ, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Scott GF, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest G, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, and Cosgrove SE. Daptomycin versus Standard Therapy for Bacteremia and Endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006 Aug 17; 355(7):653-65

9) Clancy M, Graepler A, Wilson M, Johnson J, Douglas I, Price C. Active Surveillance is Effective in Reducing Methicillin-Resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2006; 27(10):1009-17.

10) Clancy MJ, Graepler A, Breese P, Price CS, Burman WJ. The Widespread Emergence of Methicillin Resistance in Community-acquired Staphylococcus aureus Infections. Southern Medical Journal. 2005 98(11):1069-75

11) Huang R, Mehta S, Weed D, Price C. Methicillin-Resistant Staphylococcus aureus (MRSA) Survival on Hospital Fomites. Infect Control Hosp Epidemiol. Infect Control Hosp Epidemiol. 2006; 27(11):1267-9.

12) Climo M, Diekema D, Fraser V, Herwaldt L, Perl T, Peterson L, Plaskett T, Price C, Sepkowitz K, Solomon S, Tokars J, and Wong E. Prevalence of Central Venous Access Device (CVC) Use In and Outside the Intensive Care Unit: Results of a Survey Among Hospitals in Center for Disease Control and Prevention’s (CDC) Prevention Epicenter Program. Infect Control Hosp Epidemiol. 2003; 24(12):942-5.

13) Price C, Paule S, Noskin G, and Peterson L. Active Surveillance Reduces Vancomycin-Resistant Enterococci (VRE) Blood Stream Isolates. Clin Infect Dis. 2003; 37(7):921-8..

14) Price C, Jansto L, Hacek D, Noskin G, and Peterson L. Outbreak of Bloodstream Infections (BSI) in an Outpatient Hemodialysis (HD) Center. Infect Control Hosp Epidemiol. 2002; 23(12): 725-729

15) Price CS, Huynh H, Paule S, Hollis R, Noskin G, Pfaller M, and Peterson L. Comparison of an Automated Ribotyping System to Restriction Endonuclease Analysis and Pulsed-Field Gel Electrophoresis for differentiating Vancomycin- Resistant Enterococcus faecium. J Clin Microbiol 2001; 40(5): 1858-1861.

16) Price CS, Pfaller MA, Kruszynski JA, Hollis RJ, Noskin GA, and Peterson LR. Comparison of Genomic Methods for Differentiating Strains of Enterococcus faecium: An Assessment Using Clinical Epidemiologic Data. J Clin Microbiol; 36(11): 3327-3331